





ORIGINAL ARTICLE: Clinical Endoscopy
Polysomy and p16 deletion by fluorescence in situ hybridization in the
diagnosis of indeterminate biliary strictures
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Shahzad Iqbal, MD,1 Susana Gonzalez, MD,1 Subhadra V. Nandula, MD,2 Jean C. Emond, MD,4
Robert S. Brown, MD, MPH,1,4 Vundavalli V. Murty, PhD,2 Peter D. Stevens, MD1
New York, New York, USA
Background: The diagnosis of indeterminate biliary strictures is limited because of the low sensitivity of
cytology. However, an accurate diagnosis of malignancy is critical in the management of patients with suspected
biliary malignancy. Testing for chromosomal aneuploidy by fluorescence in situ hybridization (FISH) may
increase the yield.
Objective: To evaluate the diagnostic accuracy of FISH in indeterminate biliary strictures and the additional
value of including deletion of 9p21 (p16) in the diagnostic criteria of malignant biliary strictures.
Design: Retrospective review.
Setting: Academic medical center.
Patients: This study involved 76 consecutive patients who were seen for the evaluation of indeterminate
strictures at our institution. These patients were screened, and 50 patients with either a final pathologic diagnosis
or 12 months’ conclusive follow-up were included in the analysis.
Main Outcome Measurements: Sensitivity, specificity, and area under the curve (AUC) analysis of cytology
alone compared with the presence of FISH polysomy versus FISH polysomy and 9p21 deletion.
Results: The presence of increased copy numbers (polysomy) of chromosome 3, 7, or 17 by FISH increased the
sensitivity of brush cytology from 21% to 58%, and when the presence of 9p21 deletion was included, the
sensitivity increased to 89%. The specificity of FISH was 97% (vs 100% for cytology). The accuracy of cytology
combined with FISH polysomy (AUC  0.93) or p16 deletion was significantly greater than the accuracy of
cytology alone (AUC 0.6; P  .001) or even cytology combined with FISH polysomy (AUC  0.77; P  .05).
Limitations: Sample size. There is a relatively high incidence of malignant biliary strictures in the entire cohort
but low incidence among primary sclerosing cholangitis patients, and the majority of cancers are cholangiocar-
cinomas (as opposed to pancreatic).
Conclusion: FISH significantly improves the diagnostic accuracy of brush cytology in indeterminate biliary
strictures. In our series, the addition of 9p21 deletion to FISH polysomy and cytology further improved sensitivity.
This suggests that 9p21 deletion may be added to the diagnostic criteria in indeterminate strictures. (Gastrointest
Endosc 2012;75:74-9.)Abbreviations: AUC, area under the curve; CEP, chromosome enumera-
tion probe; CI, confidence interval; FISH, fluorescence in situ hybridiza-
tion; PSC, primary sclerosing cholangitis; ROC, receiver operating char-
acteristic.
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Gonda et al Polysomy and p16 deletion in indeterminate biliary stricturesBiliary strictures are most often evaluated by ERCP or
percutaneous transhepatic cholangiography. Although sig-
nificant advances have been made in the available thera-
pies of both benign and malignant strictures, diagnostic
distinction between these two entities remains one of the
greatest challenges in the field.1,2 A biliary stricture is
esignated as indeterminate when imaging and other mo-
alities fail to reveal an associated mass or evidence of
etastatic disease or when there is no associated etiology,
uch as stone disease or recent bile duct trauma.
It is suspected that the growth pattern and anatomic
ocation makes sampling, and therefore accurate diagno-
is, especially difficult.3 Advances in chemoradiation ther-
py and intraductal therapies (ie, photodynamic therapy)
s well as liver transplantation protocols have yielded
ramatic survival benefits4,5 in cholangiocarcinoma, and
this further emphasizes the need for accurate and timely
diagnosis.
Multiple procedural modalities and sampling tech-
niques have been used for the evaluation of indeterminate
strictures. Cytology, obtained by brushing of strictures
during either ERCP or percutaneous transhepatic cholan-
giography, has been the mainstay of diagnosis. Given that
the specificity of cytology is almost 100%, there is little
need for further evaluation with a positive result. How-
ever, brush cytology has poor diagnostic sensitivity that
ranges from 5% to 40%.6,7 Direct bile-duct biopsies,
cholangioscopically guided biopsies, and improved imag-
ing of the biliary epithelium may further enhance accu-
racy, but these modalities require additional procedures
and expertise. The sensitivity of these modalities is also
variable.
Fluorescence in situ hybridization (FISH) assesses the
presence of chromosomal aneuploidy (abnormality in
chromosome number) and uses fluorescence-labeled
probes to evaluate increases or decreases in chromosome
number.8 This analysis is performed on brush specimens
nd can provide accurate diagnosis when only a few
eoplastic cells are present in the sample. Previous studies
erformed predominantly by researchers at the Mayo
linic have evaluated several chromosomal regions and
ave determined that polysomy of chromosomes 3, 7,
nd 17 centromeric regions was most useful for the
iagnosis of malignancy. These studies have demon-
trated that FISH polysomy improved sensitivity (45%-
9%) when combined with cytology versus cytology
lone, whereas specificity remained near 100%.7,9,10
When trisomy was considered positive, sensitivity im-
proved, but specificity decreased, especially in patients
with primary sclerosing cholangitis (PSC) (the specific-
ity was 93%-95% in patients without PSC vs 70%-87% in
patients with PSC). These series did not include p16
deletion among the positive diagnostic criteria for FISH.
The tumor suppressor gene p16INK4a regulates cell cycle
entry and is frequently inactivated by genetic (mutations
or deletions) and epigenetic (promoter hypermethylation) t
www.giejournal.org Vechanisms. Although the frequent decrease in p16 ex-
ression observed in cholangiocarcinoma may be due to
ny of these mechanisms, prior works have suggested that
here is allelic loss of 9p21 in the majority of cases. We
ypothesized, based on this observation, that the detec-
ion of homozygous or heterozygous deletion of the 9p21
ocus (p16) can increase the diagnostic yield in biliary
alignancy.11-13 Therefore, the goal of our study was to
alidate the diagnostic accuracy of FISH polysomy and
etermine whether inclusion of p16 deletion in the diag-




This study was approved by the Institutional Review
oard of Columbia University. All consecutive patients
ho underwent ERCP or percutaneous transhepatic
holangiography at our institution for the evaluation of
ndeterminate strictures and had biliary brush cytology
nd FISH specimens obtained between February 2008 and
ebruary 2010 were included. Patients were excluded if
hey had biliary sampling without a dominant stricture
such as in PSC) or if sampling was done for abnormalities
ther than a stricture on the cholangiogram. An indeter-
inate stricture was defined as a biliary duct narrowing or
bstruction that was not associated with a known malig-
ancy or mass and was not associated with recent bile
uct trauma, surgery, or stone disease. Only patients who
ad 12 months’ follow-up or a final pathologic diagnosis
ere included in the study. A stricture was designated as
enign if at 12 months’ follow-up repeat imaging, repeat
rocedure, or repeat laboratory testing was performed,
nd these documented the resolution of the stricture or
rior abnormalities. A diagnosis of malignant stricture was
ade when either subsequent biopsy or cytology speci-
ens demonstrated malignancy, final pathology was ob-
ained by surgery, or if the cause of death was biliary
alignancy. The diagnosis of PSC was made based on
holangiographic findings associated with laboratory ab-
ormalities or liver biopsy and lack of other etiology as the
ause of stricture. Cholangitis was diagnosed when biliary
bstruction was accompanied by fever, shock, mental sta-
Take-home Message
● Complementing prior works on the use of fluorescence in
situ hybridization in biliary diagnostics, the results of this
study suggest that the inclusion of polysomy or p16
deletion improved accuracy of cancer diagnosis.us changes, or an elevated white blood cell count.





















Polysomy and p16 deletion in indeterminate biliary strictures Gonda et alSpecimen collection
Samples were obtained by using two standard cytol-
ogy brushes (Boston Scientific, Cambridge, Mass). The
first brush was always used to obtain cytology speci-
mens, which were then analyzed by a pathologist and
classified as “no malignancy,” “atypical,” “suspicious,”
or “malignant.” A positive result for the purposes of this
study included only malignant specimens (among the few
cytology-positive cases, there were no suspicious diagno-
ses). For the FISH analysis, a separate brush was used
(always following the taking of the cytology specimen).
Specimens were obtained with at least 10 to-and-fro mo-
tions at the site of the dominant stricture for both cytology
and FISH specimens. The brush was cut and placed into 15
mL of ThinPrep CytoLyt solution (Marlborough, Mass) and
was transferred to the cytogenetics laboratory within 24
hours.
Fluorescence in situ hybridization
Cells were fixed twice by using freshly made 3:1
methanol-acetic acid. Cytospin cell preparations were
made and stored at room temperature. FISH was per-
formed by using the standard protocols and commercially
available probes specific to centromeres of chromosomes
3 (chromosome enumeration probe [CEP] 3, orange), 7
(CEP 7, green), and 17 (CEP 17, aqua) in 1 hybridization
and p16 (9p21, orange/centromere 9, green) in the second
hybridization. An additional hybridization probe (Urovys-
ion; Abbott Molecular, Des Plaines, Ill) consisting of CEP 3
(orange), CEP 7 (green), CEP 17 (aqua), and 9p21 (p16,
gold) was used in some cases. Fluorescent signals were
scored on 25 to 100 cells on 4=,6-diamidino-2-pheylindole
(DAPI)-stained slides by using the Cytovision Imaging
system attached to a Nikon Eclipse 600 microscope (Ap-
plied Imaging, Santa Clara, Calif). The following criteria
were applied to select the cells to score: larger nuclear
size, irregular nuclear shape, patchy DAPI stain, and clus-
tered but not overlapped cells. Signals were recorded as
polysomy when there was a gain of two or more chromo-
somes in at least 5 cells. Homozygous deletion of 9p21/
p16 was considered when both copies were absent in at
least 10 cells as per scoring criteria suggested by the
manufacturer (Abbott Molecular, Des Plaines, Ill), or if
there was heterozygous deletion in at least 6% of the total
cells analyzed, the variation that was established by using
normal specimens in the laboratory. We established nor-
mal cutoff values in the laboratory for each of the probe
set combinations by using normal tissues and from normal
biliary tissue obtained in prior resections of benign dis-
ease. For the CEP 3, CEP 7, and CEP 17 probe combina-
tions, the normal variation for at least two trisomies was
2% at a 95% confidence interval (CI). For the 9p21/CEP 9
probe, it was 0% for homozygous deletion and 6% for
heterozygous deletion at a 95% CI. Examples of these
chromosomal abnormalities are shown in Figure 1. b
76 GASTROINTESTINAL ENDOSCOPY Volume 75, No. 1 : 2012tatistical analysis
Binomial exact 95% CIs were estimated for all sensitiv-
ties and specificities. Receiver operating characteristic
ROC) curves were built by using MedCalc 11.3 (MedCalc
oftware; Mariakerke, Belgium). The binomial exact
ethod was applied to estimate the 95% CI of the areas
nder the curve (AUC), and pair-wise comparisons of ROC
urves were performed by using a nonparametric ap-
roach.14 Although our study was retrospective, we esti-
ated power for a paired ROC comparison in n  50,
igure 2. Study design. Seventy-six patients were screened, and 50 were
ncluded in the analysis. PSC, primary sclerosing cholangitis.
igure 1. Examples of cytogenetic abnormalities seen in cholangiocar-
inoma. A, Trisomy of CEP 3, 7, and 17 demonstrated by 3 copies of red,
reen, and aqua color probes in 3 cells. B, Polysomy (4 copies/cell) of
EP 3, 7, and 17. C, Heterozygous deletion of 9p21 demonstrated by the
resence of only 1 gold-colored probe. The cells contain two copies of
EP 3, 7, and 17. D, Homozygous deletion of 9p21 demonstrated by the
bsence of gold-colored probes in 5 abnormal cells compared with 1
ormal cell (arrow) that contains two copies. All cells contain two copies



































Gonda et al Polysomy and p16 deletion in indeterminate biliary stricturesor cytology combined with 9p21 deletion. For a prespeci-
fied alpha  0.05, assuming AUC  0.70 for the first
strategy based on prior results and a correlation r  0.6
between curves, the paired ROC comparison had a power
of 60% to detect an improvement to AUC  0.85 and a
power of 86% for an improvement to AUC  0.90 after the
addition of 9p21 deletion.
RESULTS
Clinical and histologic characteristics
Seventy-six patients underwent ERCP or percutaneous
transhepatic cholangiography, with tissue obtained for cy-
tology, and FISH during the period of the study. A total of
50 patients underwent surgery, reached a final diagnosis,
or had reached 12 months’ of follow-up (Fig. 2). Twenty-
six patients were not included in the analysis because
follow-up had not reached 12 months (15/26) or patients
were lost to follow-up (8/26) or died within 12 months of
the procedure (3/26). Of the 50 patients, 21 had PSC, and
in this group one cholangiocarcinoma was identified. Of
the 29 patients without PSC, 19 were found to have ma-
lignancy, with 15 cholangiocarcinomas and 3 pancreatic
adenocarcinomas diagnosed. The final diagnosis of malig-
nancy was made at the time of resection in 7 cases, by
surgical biopsy in 4 cases, by subsequent endoscopic
sampling in 5 cases (by intraductal biopsies in 3 and
EUS-guided FNA in 2), or based on the stated cause of
death in 3 cases. There was an even distribution of prox-
imal (27/50) and distal (23/50) biliary strictures. Nineteen
of these patients underwent a prior procedure (ERCP), and
15 patients had a stent placed. None of these patients had
a diagnostic cytology, and in all cases a cytology was
obtained at the initial procedure. Eight of 15 patients who
had stents placed had cancer, and in none of these cases
TABLE 1. Diagnostic characteristics
Characteristic* Cytology FISH polysomy
Sensitivity 4/19 (21) 9/19 (47)
Specificity 31/31 (100) 30/31 (97)
PPV 4/4 (100) 9/10 (90)
NPV 31/46 (67) 30/40 (75)
AUC (95% CI) 0.605 (0.457-0.741) 0.721 (0.576-0.838)†
FISH, Fluorescence in situ hybridization; PPV, positive predictive value; NPV, ne
*The sensitivity, specificity, NPV, and PPV of different diagnostic strategies wh
AUC by using a binomial distribution.
†P  .05.
‡P  .001 represents difference compared with the cytology alone diagnostic
§P  .05 represents comparison to the cytology or FISH polysomy (third categwas a cytologic diagnosis made during the second proce- i
www.giejournal.org Vure. Significantly more men (14) than women (5) were
iagnosed with cancer (P  .05).
iagnostic techniques: combination of
olysomy and p16 deletion significantly
mproves diagnostic sensitivity
Cytology alone had a sensitivity and specificity of 22%
nd 100%, respectively, for diagnosing malignancy. FISH
olysomy of chromosome 3, 7, or 17 had a sensitivity and
pecificity of 47% and 97%, respectively. When we in-
luded 9p21 heterozygous and homozygous deletions,
ISH sensitivity increased to 84%, with preserved specific-
ty of 97%. In the majority of these cases, there was either
ow cellularity (15/17) in the specimen, or only benign
ells were seen (2/17). Combined cytology and FISH (con-
idered positive if either were positive) yielded a sensitiv-
ty of 89%, specificity of 97%, positive predictive value of
4%, and negative predictive value of 94% (Table 1).
verall, there was one false-positive sample, which had
n unusual pattern of chromosomal abnormality, showing
etraploidy of chromosome 9 (9p21) and disomy of chro-
osomes 3, 7, and 17. It was classified as a positive
nding, based on the increase in copy numbers at the
p21 locus, although the biologic significance of this is not
nown. This sample was considered positive, based on
he presence of an increased copy number and despite not
eeting formal criteria for polysomy, and it was included
n this group as a false positive. This patient had PSC and
ubsequently underwent liver transplantation for recurrent
holangitis. No dysplasia was noted in the explanted liver.
Of note, one additional chromosomal abnormality was
oted in our series in a patient with PSC who had trisomy
f chromosome 7. However, previous studies have shown
his abnormality to be particularly common in PSC-








1/19 (58) 16/19 (84) 17/19 (89)
0/31 (97) 30/31 (97) 30/31 (97)
1/12 (92) 16/17 (94) 17/18 (94)
0/38 (79) 30/33 (91) 30/32 (94)
(0633-0.880)† 0.905 (0.788-0.970)‡ 0.931 (0.823-0.983)‡,§
predictive value; AUC, area under the curve; CI, confidence interval.









strateng was not considered positive in this series.15


































































Polysomy and p16 deletion in indeterminate biliary strictures Gonda et alThe overall diagnostic accuracy (or the sensitivity and
specificity trade-off) was determined by calculating the
AUC for cytology alone versus cytology combined with
polysomy versus cytology combined with either polysomy
or 9p21 deletion. Compared with cytology alone, there
was a significant difference between FISH polysomy, poly-
somy or cytology (P  .05), polysomy or 9p21 deletion
P  .001), and polysomy or 9p21 deletion or cytology
P .05). (Table 1).
Pattern of chromosomal abnormalities in
biliary malignancy
In Table 2, we show the diagnostic modality and the
attern of chromosomal abnormalities that were seen in
alignant cases. The p16 deletion can be observed fre-
uently in highly aneuploid tumors, but in 5 cases it was
he single abnormality noted (in 2 cases only 9p21 ho-
ozygous deletion was noted, and in 3 cases only
eterozygous deletion was seen). Aneuploidy of chromo-
ome 17 or 9p21 heterozygous or homozygous deletion,
ased on the patterns of chromosomal abnormalities
oted, would have been sufficient to diagnose all of our
ases.
DISCUSSION
The recent improvement in outcomes of medical and
surgical treatment options for malignant biliary strictures
highlights the importance of accurate diagnosis of indeter-
minate strictures.1,4 Advances in imaging and cholangios-
opy will continue to enhance our ability to characterize
hese strictures and target samples and perhaps guide
herapy.16 Inherent to the growth pattern of bile duct
cancers, it is likely that both cytology and biopsy will yield
only a small amount of malignant cells. FISH allows the
detection and recognition of a very small fraction of ab-
normal cells in a brush specimen and is therefore partic-
TABLE 2. Frequency of chromosomal abnormalities in
malignant cases
Chromosomal abnormality No. (%), n  19
Aneuploidy chromosome 3 10 (52)
Aneuploidy chromosome 7 10 (52)
Aneuploidy chromosome 17 11 (57)
Heterozygous 9p21 deletion 7 (36)
Homozygous 9p21 deletion 5 (26)
Polysomy without 9p21 deletion 9 (47)
9p21 deletion without polysomy 7 (36)ularly suited for diagnostic use in these cases. p
78 GASTROINTESTINAL ENDOSCOPY Volume 75, No. 1 : 2012In our single-center study, FISH clearly increased the
iagnostic accuracy of cytology. Our findings validate
rior observations7,10,15,17 and provide additional data
rom an independent center as well as new data, with the
nclusion of the 9p21 probe.
Importantly, there was only one false-positive FISH
pecimen. The significance of an isolated tetraploidy of
hromosome 9 (in the absence of an increased copy num-
er of other chromosomal regions) is not known, and
urther studies may need to assess the independent signif-
cance of this abnormality. It is important to note that this
bnormality would not meet our formal criteria for malig-
ancy. Prior studies have shown that the majority of false-
ositive cytology results also are obtained in patients with
SCs, and certain trisomies are observed in the absence of
alignancies.18 Further and larger-scale studies will be
eeded to assess the significance of chromosome 9
etraploidy.
Although the 9p21 probe has been included in the
robe array used by prior studies, this is the first study to
eport the use of 9p21 deletion in the absence of other
olysomies as part of the diagnostic criteria for malig-
ancy. We propose, based on the significantly improved
ccuracy resulting from sensitivity increased from 47% to
4% and unchanged specificity, that future studies should
valuate and consider the inclusion of 9p21 among the
iagnostic criteria of FISH in indeterminate strictures. In
his series, two probes (CEP 17 and 9p21) would have
een sufficient to diagnose all lesions, and, therefore,
urther prospective studies may further narrow the num-
er of probes used to diagnose cancer.
Importantly, there was only one cancer that was not
iagnosed by FISH and had positive cytology, and there
ere two cancers with negative FISH and cytology. Two of
hese patients had distal biliary strictures secondary to
ancreatic adenocarcinoma, and one patient had an intra-
epatic cholangiocarcinoma. Both of these locations may
e difficult to sample with a brush, and this may account
or the false-negative results. The incorporation of EUS-
uided FNA and targeted biliary biopsies will likely im-
rove the diagnostic yield in these anatomic locations.
There are several limitations to this study, which may
mpact interpretation of the results. Because our sample
ize was small, there is a chance for a type I error (as
anifest in the width of the 95% CIs of the areas under the
OC curves). There was a relatively high proportion of
alignant strictures among the non-PSC cases and, on the
ontrary, a surprisingly low incidence of aneuploidy as
ell as malignancy among patients with PSC. The preva-
ence of cholangiocarcinoma in PSC is between 5% and
6%, based on prior series, whereas the rate of malignancy
n indeterminate strictures is expected to be much higher
70%).19 The likely difference from these numbers may
eflect the referral bias of our institution. The spectrum of
alignancy, unlike in prior studies, also reflects a higher












Gonda et al Polysomy and p16 deletion in indeterminate biliary stricturesa greater number of either pancreatic cancer or metastatic
disease). Therefore, it is difficult to ascertain from this
study whether FISH has a different role in the case of
suspected pancreatic cancer–related indeterminate stric-
tures versus suspected cholangiocarcinomas.
In conclusion, our data and data from the Mayo Clinic
support the use of FISH in the diagnostic evaluation of
indeterminate biliary strictures. The estimated per-patient
cost of a FISH analysis at this institution is $500 to $1000.
Given the economic ramifications of this test, one could
consider limiting FISH evaluation to strictures for which
cytology was nondiagnostic. Because cytology specimens
remain stable for several days in CytoLyt, this timeframe
can be sufficient to make a cytologic assessment and
proceed to FISH analysis only if a diagnosis is not made.
Further prospective studies may be necessary to define the
precise diagnostic algorithm of indeterminate stricture
evaluation, and these studies will likely answer whether
FISH should be included in the primary evaluation of all
strictures. Future research also may consider including
aneuploidy of other chromosomal regions to increase di-
agnostic yield.
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